Roche PS Par
Roche Holding AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. The company is a global leader in oncology, immunology, infectious diseases, ophthalmology, and centralized tissue diagnostics, discovering, developing, and manufacturing innovative prescription medicines and diagnostic instruments for hospitals and laboratories. Its core business operations encompass biopharmaceutical research, clinical drug development, in vitro diagnostic manufacturing, and global healthcare wholesale distribution. Revenue is derived directly from the global wholesale sale of pharmaceutical drugs and diagnostic laboratory systems. Roche holds a dominant global market position in oncology therapeutics and in vitro clinical diagnostics. The company is headquartered in Basel, Switzerland, and its non-voting equity securities (participation certificates) trade on the SIX Swiss Exchange.
4 of the funds FundTelligence covers report a position in Roche PS Par.
- Legal name
- ROCHE PS PAR AG
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 4
Funds holding Roche PS Par
- BGF World Healthscience Fund — BlackRock · 4.87 % (largest positions only, October 2026)
- BNP Quant Equity Europe Guru — BNP Paribas · 3.36 % (largest positions only, October 2026)
- iShares Europe ex-UK Index Fund (IE) — BlackRock · 2.77 % (largest positions only, September 2026)
- BNP MSCI Europe ex CW — BNP Paribas · 2.49 % (largest positions only, October 2026)